After cancer: when the scans are clear and the pain is not.

You did the hard part. Now your oncologist says things look good, and your body has not got the message.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

Getting the diagnosis right comes first

Cancer is a group of diseases in which abnormal cells multiply and can invade nearby tissue or spread to distant parts of the body (these are malignant tumours, as opposed to benign ones, which can grow but do not spread). It must be diagnosed and treated by an oncology team. No part of this article suggests otherwise.

If you have a new, persistent or worsening symptom, especially unexplained weight loss, a new lump, bleeding, a change in bowel or bladder habits, night sweats, a cough that will not go, or new pain that wakes you at night, see your doctor promptly. If you are a cancer survivor, report new symptoms to your oncology team so they can rule out recurrence. That evaluation is always step one, and the ATNS index assumes it has been done thoroughly.

The neuroplastic contribution

The ATNS Index of Neuroplastic Symptoms says cancer is not caused by neuroplastic symptoms, but that neuroplastic symptoms should be evaluated when symptoms are not fully accounted for by the cancer. In practice this usually means one of two situations.

The first is survivorship. Treatment ends, the scans are clear, but pain at the surgical site, aching in the limbs, widespread body pain, fatigue or brain fog carries on for months or years. The second is during or after treatment, when a symptom is bigger, broader or more persistent than the disease and its treatment can explain.

Neuroplastic symptoms are real physical symptoms produced by learned pathways in the brain and nervous system rather than by ongoing damage in the body. Cancer is about the most threatening thing a body can go through: the diagnosis, surgery, chemotherapy, radiation, fear of recurrence, and the months of scanning your body for signs. It is no surprise that the nervous system can stay in a protective, sensitized state after the threat is gone. The pain is not imagined and it is not weakness. It is an alarm that has learned to stay on. And because it is learned, it can be unlearned.

What the research shows

This is one of the better-studied areas on the index, because cancer survivorship research has caught up with pain science.

A 2023 state-of-the-art review on central sensitization in cancer survivors concludes that central sensitization, the nervous system amplifying signals, is a key driver of chronic pain in people who have finished cancer treatment. It notes, for example, that survivors with persistent pain after breast cancer surgery show reduced ability to dampen pain signals and heightened summation of repeated stimuli compared with survivors without pain.

A 2018 study of chronic pain in breast cancer survivors classified pain as nociceptive (from tissue), neuropathic (from nerve injury) or central sensitization pain. About 15 percent had predominantly central sensitization pain, and roughly 40 percent had mixed pain, so many survivors had a nervous-system component alongside other causes. The authors also noticed an association between central sensitization pain and hormone therapy, which they flagged for further study.

A 2024 phenotyping study using the international CANPPHE guidelines found similar proportions in breast cancer survivors: pain was predominantly neuropathic in 22 percent, nociceptive in 21 percent and nociplastic in 16 percent. Survivors with predominantly nociplastic pain had the lowest quality of life for bodily pain and social functioning, and the authors stress that this type of pain responds poorly to opioids, which makes identifying it important.

Honest summary: these are mostly breast cancer studies and modest in size, and the proportions vary. But they agree that a meaningful share of post-cancer pain is driven by a sensitized nervous system, and that treating it as if it were tissue damage does not work well.

Signs the brain may be part of the picture

• Your oncology team has confirmed there is no recurrence, yet pain or fatigue continues or worsens.
• Pain has spread beyond the surgical or treatment site, or moves around.
• Light touch, clothing or mild pressure hurts in areas with no visible damage.
• Symptoms flare with scans, follow-up appointments, anniversaries or news about someone else's cancer.
• Pain medication helps less than expected, or opioids do little.

A solution that addresses it

There is an approach that addresses the brain's contribution to post-cancer symptoms. Pain and symptom reprocessing combines education about neuroplastic symptoms, somatic tracking (observing a sensation with calm attention), reducing fear and threat, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. It is delivered by trained clinicians and increasingly through digital programs, and it belongs alongside your oncology follow-up, never in place of it.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If you are through treatment and your body has not caught up, you can join the waitlist.

What to do next

First, keep every oncology follow-up and report new or changing symptoms promptly. Recurrence, treatment side effects, nerve injury and bone problems all need proper assessment, and your team is the right place to start.

Second, once those have been checked, ask whether your pain or fatigue fits a nociplastic or neuroplastic pattern. Some oncology and pain services now assess for central sensitization directly; it is reasonable to ask.

Third, if it might fit, start learning and practising. Read about hurt versus harm, use the practice below, and build activity back in small steps using pacing. Fear of recurrence is a normal part of survivorship, and working with it directly is part of the recovery, not a distraction from it.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.